Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nanjing Baikang Biotechnology

Request full access

Innovative antibody solutions for diagnostics and therapeutic applications, enhancing precision in healthcare

ChinaFounded 2019Biotech & Life Sciences

About Nanjing Baikang Biotechnology

Bioantibody is a biotechnology company specializing in the development and production of high-quality antibodies for diagnostic and therapeutic use. Operating in the healthcare and life sciences market, Bioantibody serves a diverse range of clients including research institutions, pharmaceutical companies, and clinical laboratories. The company’s business model revolves around the creation and sale of custom antibodies, which are critical for various applications such as disease diagnosis, vaccine development, and therapeutic treatments. Revenue is generated through the direct sale of these antibodies and related services, including custom antibody production and consultation. Bioantibody leverages advanced technologies and rigorous quality control to ensure the efficacy and reliability of its products, positioning itself as a key player in the biotechnology sector.

Source: Dealroom company data

At a glance

Status
Operational
Employees
14
Open positions
None listed
Dealroom signal
44.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jan 2023 $14M $55M Xingong Industrial Investment · Bangsheng Capital · Fang Fund Partners · Guoqian Venture Capital ↗
SPINOUT✓Other financing Jan 2019 $0 — Nanjing University —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Nanjing Baikang Biotechnology website traffic

Latest recorded traffic for Nanjing Baikang Biotechnology is 90 monthly website visits, up 200% over the last three months. Nanjing Baikang Biotechnology's team grew 27.3% over the past year.

Latest monthly visits90 3-month web change+200% 1-year team growth+27.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nanjing Baikang Biotechnology in its local ecosystem

Live from Dealroom

The Nanjing Baikang Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Fang Fund Partners
  • Xingong Industrial Investment
  • Bangsheng Capital
  • Guoqian Venture Capital

Other known investors1 additional known investor

  • Nanjing University
Employees 14 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China88.9%
🇭🇰 Hong Kong11.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nanjing Baikang Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nanjing Baikang Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.